In order to evaluate the association of AGR2 and cell cycle molecules in ovarian cancer and its implications on prognosis, we have used immunohistochemistry to investigate protein expression of AGR2, p21, cyclin D, and p53. Here, CDKN1A is linked to ovarian cancer.